RSV Burden in Outpatient and Hospital Settings
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-24
SponsorAssociation Clinique Thérapeutique Infantile du val de Marne
About this trial
Strengthening outpatient low respiratory tract infection surveillance to document the burden of Respiratory Syncytial Virus (RSV)
Eligibility criteria
Qualifiers
children under 24 months of age (≤)
One of the holders of parental authority signed the consent
Patient affiliated to a social security scheme (Social Security or Universal Medical Coverage)
Acute purulent otitis media (Paradise Criteria) or otorrhea with or withitout associated bronchiolitis
Disqualifiers
Age >24 months
Refusal by one of the parents
Not affiliated to a social security system
Maternal RSV vaccination during the pregnancy of the included child
Trial design
Treatments tested in this trial
- nasopharyngeal samples
Treatment groups
1,900 Participants
are divided into 2 treatment groupsSponsors and collaborators
Association Clinique Thérapeutique Infantile du val de Marne
Lead sponsor
Sanofi
Collaborator
Source ClinicalTrials.gov